patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
Daptomycin Novo
Marketedupdated 2mo agoby Xellia Pharmaceuticals USA LLC
Approvedcommunity read0 votes
all catalysts(9)
approval · 9
Jul 12, 2019
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Jun 29, 2021
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Jun 29, 2021
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Nov 13, 2022
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Nov 13, 2022
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Mar 22, 2023
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Jan 26, 2026
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Jan 30, 2026
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Mar 13, 2026
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that